Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND SUPPLEMENTAL DISCLOSURES (Details Narrative)

v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND SUPPLEMENTAL DISCLOSURES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Nov. 07, 2022
Oct. 25, 2022
Apr. 20, 2022
Jan. 12, 2022
Sep. 30, 2022
Sep. 30, 2021
Jun. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Sep. 29, 2022
Product Information [Line Items]                      
Net loss         $ 8,028,000 $ 8,805,000   $ 21,391,000 $ 28,962,000    
Net cash used in operating activities               $ 15,975,000 20,511,000    
Common stock, par value         $ 0.0001     $ 0.0001   $ 0.0001  
Repayments of Debt               $ 5,381,000 $ 7,162,000    
Cash and Cash Equivalents, at Carrying Value         $ 921,000     921,000   $ 937,000  
Employee Retention Credit provisions           $ 1,500 $ 1,500        
FDIC Insured Amount         $ 250,000     250,000      
Reclassification of cash               $ 2,288,000      
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Customer [Member]                      
Product Information [Line Items]                      
Concentration risk, percentage         11.00%            
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | No Customer [Member]                      
Product Information [Line Items]                      
Concentration risk, percentage           10.00%   10.00% 10.00%    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | No Customer [Member]                      
Product Information [Line Items]                      
Concentration risk, percentage               10.00%   10.00%  
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendor One [Member]                      
Product Information [Line Items]                      
Concentration risk, percentage         54.00% 17.00%   45.00% 31.00%    
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendor Two [Member]                      
Product Information [Line Items]                      
Concentration risk, percentage         11.00% 16.00%   16.00% 20.00%    
Accounts Payable [Member] | Supplier Concentration Risk [Member] | One Vendor [Member]                      
Product Information [Line Items]                      
Concentration risk, percentage               42.00%   40.00%  
Purchase [Member] | Supplier Concentration Risk [Member] | Two Vendors [Member]                      
Product Information [Line Items]                      
Concentration risk, percentage         65.00% 48.00%   61.00% 36.00%    
Share-Based Payment Arrangement, Option [Member]                      
Product Information [Line Items]                      
Antidilutive securities               5,252,119 5,528,405    
Warrant [Member]                      
Product Information [Line Items]                      
Antidilutive securities               25,651,407 11,008,302    
Restricted Stock [Member]                      
Product Information [Line Items]                      
Antidilutive securities               2,071,849 2,109,999    
Convertible Notes Due 2023 [Member]                      
Product Information [Line Items]                      
Debt converted instrument, amount               $ 1,209,610 $ 0    
Debt converted instrument, price per share         $ 3.00 $ 3.00   $ 3.00 $ 3.00    
Subsequent Event [Member] | Convertible Notes Due 2023 [Member]                      
Product Information [Line Items]                      
Debt Instrument, Periodic Payment   $ 1,172,000                  
Debt Instrument, Periodic Payment, Principal   $ 2,545,000                  
Related Party [Member]                      
Product Information [Line Items]                      
Debt converted instrument, amount               $ 808,900 $ 742,278    
Debt converted instrument, price per share         $ 1.03 $ 1.03   $ 1.03 $ 1.03    
U.S. Small Business Administration [Member]                      
Product Information [Line Items]                      
Loan payable                     $ 350,000
Common Stock Purchase Agreement [Member] | Tumim Stone Capital LLC [Member]                      
Product Information [Line Items]                      
Common stock, par value       $ 0.0001              
Shares issued, shares       607,287              
Common Stock Purchase Agreement [Member] | Tumim Stone Capital LLC [Member] | Maximum [Member]                      
Product Information [Line Items]                      
Shares issued, value       $ 50,000,000              
January Note Purchase Agreement [Member] | Three Institutional Investors [Member]                      
Product Information [Line Items]                      
Debt original principal amount       $ 6,300,000              
Securities Purchase Agreement [Member]                      
Product Information [Line Items]                      
Shares issued, shares     14,666,667                
Warrants purchase     14,666,667                
Warrant exercise price per share     $ 0.75                
Proceeds from issuance of warrants     $ 11,000,000                
Repayments of Debt     $ 1,650,000                
Securities Purchase Agreement [Member] | Subsequent Event [Member]                      
Product Information [Line Items]                      
Shares issued, shares   12,500,000                  
Warrants purchase   12,500,000                  
Warrant exercise price per share   $ 0.75                  
Proceeds from issuance of warrants   $ 4,000,000                  
Increase decrease warrant exercise price per share   $ 0.34                  
Share Price   $ 0.32                  
Securities Purchase Agreement [Member] | Series A Warrants [Member]                      
Product Information [Line Items]                      
Increase decrease warrant exercise price per share     $ 0.75                
Securities Purchase Agreement [Member] | Maximum [Member] | Series A Warrants [Member]                      
Product Information [Line Items]                      
Warrant exercise price per share     2.10                
Securities Purchase Agreement [Member] | Minimum [Member] | Series A Warrants [Member]                      
Product Information [Line Items]                      
Warrant exercise price per share     $ 1.10                
November Note Purchase Agreement [Member] | Subsequent Event [Member] | November Note Holder [Member]                      
Product Information [Line Items]                      
Debt original principal amount $ 5,470                    
Original issue discount 470                    
Debt gross proceeds $ 5,000                    
Debt instrument, description The November Note matures eighteen months following the date of issuance. Commencing six months from the date of issuance, the Company is required to make monthly cash redemption payments in an amount not to exceed $600. The November Note may be repaid in whole or in part prior to the maturity date for a 10% premium. The November Note requires the Company to use 20% of the gross proceeds raised from future equity or debt financings, or the sale of any subsidiary or material asset, to prepay the November Note, subject to a cap on the aggregate prepayment amount.